MAR 04, 2016 7:00 AM PST

Low vitamin D predicts aggressive prostate cancer

Men who are deficient in vitamin D often have more aggressive prostate cancer at the time of surgery, according to a recent study.
 
"All men should be replenishing their vitamin D to normal levels," Adam Murphy says. "It's smart preventive health care."

While other studies have shown an association between vitamin D levels and aggressive prostate cancer, they were based on blood drawn well before treatment. The new study provides a more direct correlation because it measured D levels within a couple of months before the tumor was visually identified as aggressive during surgery to remove the prostate (radical prostatectomy).

The finding can offer guidance to men and their doctors who may be considering active surveillance, in which they monitor the cancer rather than remove the prostate.

“Men with dark skin, low vitamin D intake, or low sun exposure should be tested for vitamin D deficiency when they are diagnosed with an elevated PSA or prostate cancer. Then a deficiency should be corrected with supplements,” says Adam Murphy, an assistant professor of urology at Northwestern University and lead investigator.

The relationship between vitamin D and prostate cancer may explain some disparities seen in prostate cancer, especially among African-American men. Prior research by Murphy and colleagues showed African-American men who live in low sunlight locations are up to 1½ times more likely to have vitamin D deficiency than Caucasian men.

But because vitamin D is a biomarker for bone health and aggressiveness of other diseases, all men should check their levels, Murphy says.

“All men should be replenishing their vitamin D to normal levels,” Murphy adds. “It’s smart preventive health care.”

Aggressive prostate cancer is defined by whether the cancer has migrated outside of the prostate and by a high Gleason score. A low Gleason score means the cancer tissue is similar to normal prostate tissue and less likely to spread; a high one means the cancer tissue is very different from normal and more likely to spread.

The study was part of a larger ongoing study of 1,760 men in the Chicago area examining vitamin D and prostate cancer. The current study included 190 men, average age of 64, who underwent a radical prostatectomy to remove their prostate from 2009 to 2014.

Of that group, 87 men had aggressive prostate cancer. Those with aggressive cancer had a median level of 22.7 nanograms per milliliter of vitamin D, significantly below the normal level of more than 30 nanograms/milliliter. The average D level in Chicago during the winter is about 25 nanograms/milliliter, Murphy notes.

“It’s very hard to have normal levels when you work in an office every day and because of our long winter,” he says.

The study was published in the Journal of Clinical Oncology. Murphy collaborated on the study with Rick Kittles, associate director of cancer disparities at the University of Arizona Cancer Center.

The National Institutes of Health, the Veterans Health Administration, and the US Department of Defense funded the study.

Source: Northwestern University

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
SEP 15, 2020
Cancer
Soy helps post-op treatment of bone cancer
SEP 15, 2020
Soy helps post-op treatment of bone cancer
New research published in the journal Acta Biomaterialia highlights the post-operative benefits of soy in treatment ...
OCT 05, 2020
Cancer
Fighting mitochondrial terminal exhaustion
OCT 05, 2020
Fighting mitochondrial terminal exhaustion
New findings reported in Nature Immunology highlight how the tumor microenvironment attacks the mitochondria of T l ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 18, 2020
Cancer
Could Targeting the Proteasome be Effective Against Cancer?
NOV 18, 2020
Could Targeting the Proteasome be Effective Against Cancer?
One of the trickiest things about anti-cancer drug design is targeting. Today, most drugs on the market target critical ...
NOV 23, 2020
Cancer
Women show higher survival rates than men post lung cancer surgery
NOV 23, 2020
Women show higher survival rates than men post lung cancer surgery
New research published in the journal Chest shows that women fare better than men following lung cancer surgery. Th ...
Loading Comments...